Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Debiopharm Group has signed a license and supply agreement with Medical Futures for the Canadian distribution rights to Sanvar IR, an immediate release formulation.
Subscribe to our email newsletter
The product, developed by Debiopharm for the treatment of acute esophageal variceal bleeding (EVB), is currently under review for approval by the Canadian Health Authorities.
In addition to purchasing the product directly from Debiopharm, Medical Futures is responsible for upfront and milestone payments.